期刊文献+

缺血性脑血管病患者趋化因子受体CX3CR1基因V249 I多态性的研究 被引量:1

Research on V249I polymorphisms of chemokine receptor CX3CR1 gene in patients with ischemic cerebrovascular disease
下载PDF
导出
摘要 目的探讨缺血性脑血管病(ICVD)患者趋化因子受体CX3CR1基因V249 I的多态性及其频率。方法采用聚合酶链反应和限制性片段长度多态性方法检测ICVD患者(脑梗死、腔隙性脑梗死、短暂性脑缺血发作)及健康对照者的CX3CR1基因V249 I的多态性及频率。结果对照组CX3CR1基因V249 I只有VV和VI基因型,ICVD组有VV、VI和Ⅱ3种基因型;ICVD组I等位基因频率明显高于对照组(P<0.01);CX3CR1基因型及I等位基因频率在不同类型ICVD患者之间无统计学差异。结论CX3CR1基因V249 I多态性可能与ICVD有关。 Objective To investigate chemokine receptor CX3CR1 gene V249I polymorphisms and its frequency in patients with ischemic cerebrovascular disease (ICVD) . Methods The CX3CR1 gene V249I polymorphisms and frequency of patients with ICVD( cerebral infarction, lacunar infarction, transient ischemic attack) and healthy controls were analyzed by multiplex polymerase chain reaction and restriction fragment length polymorphism. Results There were VV and VI genetypes of CX3CR1 gene V249I in control group,and VV,VI and Ⅱ genetypes in ICVD group. The frequency of I249 allele was significantly higher in ICVD group than that in control group(P 〈0.01 ). No significant differences were observed in ICVD subgroups in genetypes and I allele distribution. Conclusions CX3CR1 gene V249I polymorphism may be associated with ICVD.
机构地区 长沙市第一医院
出处 《山东医药》 CAS 北大核心 2008年第22期15-17,共3页 Shandong Medical Journal
基金 长沙市科学技术局科技计划项目(K06070027-32)
关键词 趋化因子 CX3CR1 缺血性脑血管病 chemotaticfactor CX3CR1 ischemic cerebrovascular disease
  • 相关文献

参考文献7

  • 1Faure S, Meyer L, Costaglioli B, et al. Rapid progession to AIDS in HIV^+ individual with a structural variant of the chemokine receptor CX3CRI[J]. Science, 2000, 287(5461): 2 274-2 277.
  • 2Niessner A, Marculescu R, Haschemi A, et al. Opposite effects of CX3CR1 receptor polymorphisms T280M and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation[ J]. Thromb Haemost, 2005, 93 (5) : 949-954.
  • 3Gugl A, Renner W, Seinost G, et al. Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease[ J]. Atherosclerosis, 2003, 166(2) : 339-343.
  • 4Mc Dermott DH, Colla JS, Kleeberger CA, et al. Genetic polymorphism in CX3CR1 and risk of HIV disease [ J]. Science, 2000, 290(5499) :2 031.
  • 5Hattori H, ho D, Tanahashi N, et al. T280M and V249Ⅰ polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease[J]. Neurosci Lett, 2005, 374(2) : 132-135.
  • 6徐守伟 董秋立 刘冰冰.炎症与动脉粥样硬化及斑块不稳定关系的研究进展.山东医药,2008,48(5):114-115.
  • 7Lavergne E, Labreuehe J, Daoudi M, et al. Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovaseular disease[J]. Arterioseler Thromb Vase Biol, 2005, 25 (4) : 847-853.

共引文献4

同被引文献22

  • 1彭旭,张智博,唐璐,周颖.缺血性脑血管病患者趋化因子受体CX3CR1基因T280M多态性的研究[J].临床神经病学杂志,2008,21(5):329-332. 被引量:3
  • 2代亚美,关国英,韩辉,赵庆杰,苏志强,张黎明.脑梗死患者MCP-1启动子区A-2518G基因多态性的研究[J].中风与神经疾病杂志,2006,23(2):152-154. 被引量:5
  • 3陈施艳,张志坚,吴秀丽,王志强,王伟,杨期东.单核细胞趋化蛋白-1基因-2518G/A多态性与中国湖南地区汉族人群脑梗死关系的研究[J].临床神经病学杂志,2007,20(3):167-169. 被引量:4
  • 4Lavergne E, Labreuche J, Daoudi M, et al. Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease[J]. Arterioscler Thromb Vasc Biol, 2005, 25(4): 847-853.
  • 5al Sharif F, Ollier WE, Hajeer AH. A rare polymorphism at position -28 in the human RANTES promoter[J]. Eur J Immunogenet, 1999, 26(5): 373-374.
  • 6Hajeer AH, al Sharif F, Oilier WE. A polymorphism at position -403 in the human RANTES promoter [J]. Eur J Immunogenet, 1999, 26(5): 375-376.
  • 7Um JY, Kim HM. Polymorphisms of RANTES and IL-4 genes in cerebral infarction[J]. J Mol Neurosci, 2009, 37(1): 1-5.
  • 8Afzal AR, Kiechl S, Daryani YP, et al. Common CCR5-deI32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population [J]. Stroke, 2008, 39(7): 1972-1978.
  • 9Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow [J]. J Exp Med, 1998, 188(8): 1413-1419.
  • 10Cybulsky MI, Hegele RA. The fi'actalkine receptor CX3CR1 is a key mediator of atherogenesis [J]. J Clin Invest, 2003, 111 (8): 1118-1120.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部